| Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung Cancer (NCT07436858) | The Netherlands Cancer Institute | 2026-09-07 |
| Enfortumab Vedotin + Pembrolizumab Induction to Spare the Bladder in MIBC (NCT07663747) | The Netherlands Cancer Institute | 2026-09-01 |
| Pembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With Residual Disease After Neoadjuvant Pembrolizumab Plus Chemotherapy (NCT07486687) | The Netherlands Cancer Institute | 2026-04-01 |
| Short Course of Radiotherapy Prior to Surgery of Soft Tissue Sarcomas (NCT07071727) | The Netherlands Cancer Institute | 2025-12-11 |
| Dose De-escalation in Prostate Radiotherapy Using an MR-Linac in Two Fractions (NCT07391982) | The Netherlands Cancer Institute | 2025-11-17 |
| TAO-Towards Optimal (Neo)Adjuvant Systemic Therapy of Stage III Triple-negative Breast Cancer (NCT06931769) | The Netherlands Cancer Institute | 2025-11-06 |
| Chemosensitivity During Phases of the Menstrual Cycle in Breast Cancer Patients (NCT06273800) | The Netherlands Cancer Institute | 2025-10-14 |
| Contrast-enhanced Ultrasound for Sentinel Node Detection (NCT07310758) | The Netherlands Cancer Institute | 2025-09-18 |
| Transtympanic STS Against Cisplatin-induced SNHL: the SOUND Trial (NCT07281508) | The Netherlands Cancer Institute | 2025-08-14 |
| Functional Liver After SBRT (NCT07033364) | The Netherlands Cancer Institute | 2025-07-21 |
| Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis After Radiation for High-grade Glioma or Brain Metastases (NCT06888817) | The Netherlands Cancer Institute | 2025-06-19 |
| Long-term Survivorship Challenges of Advanced/Metastatic GIST Patients Responding to Tyrosine Kinase Inhibitor Treatment: an Observational Study (NCT07522762) | The Netherlands Cancer Institute | 2025-05-21 |
| Towards Cure Via Only Ultra-short ICB in CSCC (NCT06823479) | The Netherlands Cancer Institute | 2025-05-14 |
| The PROOV Study: Exploiting the Synergistic Effect of PARP Inhibition With Cisplatin and Hyperthermia During Interval Cytoreductive Surgery and HIPEC in Ovarian Cancer (NCT07460180) | The Netherlands Cancer Institute | 2025-05-01 |
| OPTImaL:Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Tumor-infiltrating Lymphocytes (NCT06476119) | The Netherlands Cancer Institute | 2025-04-15 |
| Whole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT (NCT06222489) | The Netherlands Cancer Institute | 2025-03-03 |
| The Radium-select Study (NCT06659926) | The Netherlands Cancer Institute | 2025-02-24 |
| Earlier Detection and Optimization of Treatment and Prognosis for Patients With Early-onset Colorectal Cancer (NCT06568679) | The Netherlands Cancer Institute | 2025-01-27 |
| The Diagnostic Value of FAPI PET/CT in Staging of Newly Diagnosed Prostate Cancer (NCT06634173) | The Netherlands Cancer Institute | 2024-12-01 |
| Induction Treatment for Initially Unresectable Colorectal Liver Metastases: Combined Hepatic Arterial Infusion Pump Therapy With Systemic Therapy (NCT06857773) | The Netherlands Cancer Institute | 2024-11-21 |
| Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer (NCT06353906) | The Netherlands Cancer Institute | 2024-08-13 |
| Feasibility of Primer Shot Radiotherapy for Non-small Cell Lung Cancer - PRIMER (NCT06528743) | The Netherlands Cancer Institute | 2024-08-08 |
| Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial (NCT06855095) | The Netherlands Cancer Institute | 2024-06-25 |
| Navigated Partial Nephrectomy (NCT07315100) | The Netherlands Cancer Institute | 2024-06-20 |
| LB-100 (PP2A Inhibitor) and Atezolizumab (PD-L1 Inhibitor) in Metastatic Colorectal Cancer Patients (NCT06012734) | The Netherlands Cancer Institute | 2024-06-18 |
| NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial (NCT06342037) | The Netherlands Cancer Institute | 2024-06-12 |
| Distributed Learning of Edic and CardIac Dose Effects in Lung Cancer (NCT06329648) | The Netherlands Cancer Institute | 2024-06-01 |
| Basket Study for Oligo-metastatic Breast Cancer (NCT05982678) | The Netherlands Cancer Institute | 2024-05-02 |
| Preoperative Accelerated Partial Breast Irradiation in Patients With Locally Recurrent or Second Primary Breast Cancer (NCT06362616) | The Netherlands Cancer Institute | 2024-04-12 |
| Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma (NCT06240143) | The Netherlands Cancer Institute | 2024-03-08 |
| A Pilot Study of Dose dE-eScalaTion IN prostATe radIOtherapy usiNg the MRL (NCT06284304) | The Netherlands Cancer Institute | 2024-02-29 |
| Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab (NCT06237920) | The Netherlands Cancer Institute | 2024-02-19 |
| The Food-effect on Alectinib Pharmacokinetics (NCT05710133) | The Netherlands Cancer Institute | 2024-02-01 |
| Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel Immuno-oncology Combinations (NCT06279130) | The Netherlands Cancer Institute | 2024-01-29 |
| PEnile ReHABilitation After Nerve Sparing Robot-assisted Radical Prostatectomy for Prostate Cancer 2.0 (PEHAB-II) (NCT06875258) | The Netherlands Cancer Institute | 2024-01-15 |
| Primary Chemoradiation VS. Neoadjuvant Chemotherapy Followed By Surgery As Treatment Strategy For LAVC (NCT05905315) | The Netherlands Cancer Institute | 2024-01-01 |
| Neoadjuvant Trastuzumab, Pertuzumab and Tucatinib Without Chemotherapy in HER2-positive Breast Cancer: the TRAIN-4 Study (NCT06162559) | The Netherlands Cancer Institute | 2023-12-18 |
| Peri-operative Slow-paced Breathing to Reduce Anxiety in Breast Cancer Surgery Patients (NCT06192225) | The Netherlands Cancer Institute | 2023-11-29 |
| Radioembolisation and Chemotherapy in Liver Metastatic Breast Cancer Patients (NCT06142344) | The Netherlands Cancer Institute | 2023-10-19 |
| Feasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE) (NCT06691776) | The Netherlands Cancer Institute | 2023-08-29 |
| Galunisertib Combined With Capecitabine in Advanced CRC With PM (NCT05700656) | The Netherlands Cancer Institute | 2023-07-28 |
| Subtherapeutic Dose of Piracetam as a Therapy Adherence Marker (NCT05918341) | The Netherlands Cancer Institute | 2023-07-03 |
| Effect of a Bundle of Non-pharmacological Interventions on the Stress Response to Surgery (NCT05638152) | The Netherlands Cancer Institute | 2023-05-01 |
| Standard Moderately Hypofractionated RT vs. Ultra-hypofractionated Focal Lesion Ablative Microboost in Prostate Cancer (NCT05705921) | The Netherlands Cancer Institute | 2023-04-26 |
| COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study (NCT05301881) | The Netherlands Cancer Institute | 2023-04-17 |
| 'Cancer Patients Better Life Experience' (NCT05827289) | The Netherlands Cancer Institute | 2023-04-15 |
| Validation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node Biopsy (NCT06666634) | The Netherlands Cancer Institute | 2023-04-01 |
| Upfront Resection of Locally Advanced NSCLC Followed by Chemoradiotherapy (NCT05620199) | The Netherlands Cancer Institute | 2023-04-01 |
| Tracer-Guided Surgery for Recurrent Prostate Cancer (NCT05555017) | The Netherlands Cancer Institute | 2023-02-15 |
| Anti-PD-1 Re-challenge After Immune Priming by Ipilimumab and Immune Boosting by Radiotherapy in Advanced NSCLC (NCT05401786) | The Netherlands Cancer Institute | 2023-01-03 |
| Pembrolizumab for Locally Advanced, Irresectable, Non-metastatic dMMR Colorectal Cancers (NCT05131919) | The Netherlands Cancer Institute | 2022-12-22 |
| DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy (NCT05416164) | The Netherlands Cancer Institute | 2022-10-07 |
| FMT to Convert Response to Immunotherapy (NCT05251389) | The Netherlands Cancer Institute | 2022-08-31 |
| EffectiveNess of a Multimodal preHAbilitation Program in patieNts With Bladder canCEr Undergoing Cystectomy (NCT05480735) | The Netherlands Cancer Institute | 2022-08-11 |
| Sarcomas and DDR-Inhibition; a Combined Modality Study (NCT05116254) | The Netherlands Cancer Institute | 2022-07-18 |
| FAPI PET/CT for Lymph Node Staging in Colorectal Carcinoma (NCT05209750) | The Netherlands Cancer Institute | 2022-07-13 |
| Association of Silicone Breast Implants With Overall Wellbeingand Auto-immune Diseases (NCT05400954) | The Netherlands Cancer Institute | 2022-07-01 |
| Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer (NCT05406674) | The Netherlands Cancer Institute | 2022-06-15 |
| Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer (NCT05148546) | The Netherlands Cancer Institute | 2022-04-28 |
| Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers (NCT04916236) | The Netherlands Cancer Institute | 2022-03-31 |
| Prospective Clinical Validation of a Novel Multitarget FIT in CRC Screening (NCT05314309) | The Netherlands Cancer Institute | 2022-03-25 |
| Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC (NCT05200988) | The Netherlands Cancer Institute | 2022-03-14 |
| Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC (NCT04648189) | The Netherlands Cancer Institute | 2022-01-01 |
| EBRT + Lu-PSMA for N1M0 Prostate Cancer (NCT05162573) | The Netherlands Cancer Institute | 2021-12-20 |
| Vessel- and Bone-based Ultrasound Registration (NCT05637346) | The Netherlands Cancer Institute | 2021-12-05 |
| Improved Implant for Reconstruction Purposes After Mandibular Resection (NCT05153733) | The Netherlands Cancer Institute | 2021-11-29 |
| The Prognostic Role of Lymph Node Dissection In Men With Prostate Cancer Treated With Radical Prostatectomy (NCT05109910) | The Netherlands Cancer Institute | 2021-11-17 |
| Multispectral Fluorescence as a Tool to Separate Healthy and Disease Related Lymphatic Anatomies in Prostate Cancer. (NCT05120973) | The Netherlands Cancer Institute | 2021-11-01 |
| Pre-operative Immunotherapy in Stage II-III Urothelial Cancer (NCT04871594) | The Netherlands Cancer Institute | 2021-08-23 |
| Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma (NCT04949113) | The Netherlands Cancer Institute | 2021-07-08 |
| Image-guided Navigation During Robotic Sentinel Node Removal (NCT06091072) | The Netherlands Cancer Institute | 2021-07-01 |
| Short Course Of Preoperative Radiotherapy in Head and Neck-, Trunk- and Extremity Soft Tissue Sarcomas (NCT04425967) | The Netherlands Cancer Institute | 2021-06-25 |
| The Prospective Observational COMPRAYA Cohort Study (NCT04682470) | The Netherlands Cancer Institute | 2021-06-18 |
| Ultrasound-guided Erector Spinae Plane Block Versus Paravertebral Block in Breast Cancer Patients Undergoing Mastectomy With Immediate Reconstruction - a Non-inferiority Trial (NCT05590559) | The Netherlands Cancer Institute | 2021-06-01 |
| CYP3A4 Activity in Patients With Prostate Cancer Versus Male Patients With Other Solid Tumours (NCT05518799) | The Netherlands Cancer Institute | 2021-04-22 |
| Organ Preservation in Rectal Cancer: Contact X-ray Brachytherapy vs Extending the Waiting Interval and Local Excision (NCT05772923) | The Netherlands Cancer Institute | 2021-04-16 |
| Liquid Biopsies for Improving the Pre-operative Diagnosis of Ovarian Cancer (NCT04971421) | The Netherlands Cancer Institute | 2021-04-14 |
| Monalizumab and Trastuzumab In Metastatic HER2-pOSitive breAst Cancer: MIMOSA-trial (NCT04307329) | The Netherlands Cancer Institute | 2021-03-23 |
| Pembrolizumab Plus Lenvatinib In Second Line and Third Line Malignant Pleural mesotheLioma Patients (NCT04287829) | The Netherlands Cancer Institute | 2021-03-01 |
| International Prospective Registry on Local Treatment Approaches in MLS (NCT04699292) | The Netherlands Cancer Institute | 2021-01-18 |
| Cardiac Changes After Stereotactic Radiotherapy for Early Stage NSCLC Cancer or Lung Metastasis (NCT03984019) | The Netherlands Cancer Institute | 2021-01-13 |
| Hepatic Arterial Infusion Pump Chemotherapy Combined With Systemic Chemotherapy (PUMP-IT) (NCT04552093) | The Netherlands Cancer Institute | 2020-09-09 |
| Neo-adjuvant T-VEC + Nivolumab Combination Therapy for Resectable Early Metastatic (stage IIIB/C/D-IV M1a) Melanoma with Injectable Disease (NCT04330430) | The Netherlands Cancer Institute | 2020-09-08 |
| Neo-adjuvant Nivolumab or Nivolumab With Ipilimumab in Advanced Cutaneous Squamous Cell Carcinoma Prior to Surgery (NCT04620200) | The Netherlands Cancer Institute | 2020-08-11 |
| Tracked Ultrasound for Patient Registration in Surgical Navigation During Abdominal Cancer Surgery (NCT05637359) | The Netherlands Cancer Institute | 2020-07-13 |
| Technetium Based Radioguided Surgery for Prostate Cancer (TRACE) Study (NCT03857113) | The Netherlands Cancer Institute | 2020-03-11 |
| Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Patients (NCT04159818) | The Netherlands Cancer Institute | 2020-02-21 |
| Diagnostic Yield of Colonoscopy Surveillance in Testicular Cancer Survivors Treated With Platinum-based Chemotherapy (NCT04180033) | The Netherlands Cancer Institute | 2020-02-18 |
| Cardiotoxicity and Other Late Effects After Radiotherapy and Immuno-chemoTherapy in Non-Hodgkin lYmphoma (NCT07041827) | The Netherlands Cancer Institute | 2020-02-01 |
| Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel Chemotherapy (NCT04161664) | The Netherlands Cancer Institute | 2020-01-16 |
| Improving the Safety of Fluoropyrimidine-based Chemotherapy (NCT04194957) | The Netherlands Cancer Institute | 2020-01-15 |
| Treatment of Locally Advanced VULvar CArcinoma in a Neoadjuvant Setting With Carboplatin and Paclitaxel Chemotherapy (VULCANize) (NCT04192253) | The Netherlands Cancer Institute | 2020-01-14 |
| Multicenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat, Nivolumab and Ipilimumab in IFN-gamma Signature-low and IFN-gamma Signature-high RECIST 1.1-measurable Stage III Cutaneous or Unknown Primary Melanoma (NCT04133948) | The Netherlands Cancer Institute | 2020-01-07 |
| Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (NCT03772028) | The Netherlands Cancer Institute | 2020-01-01 |
| Avoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy (NCT04225858) | The Netherlands Cancer Institute | 2020-01-01 |
| LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615) (NCT04031872) | The Netherlands Cancer Institute | 2020-01-01 |
| Propranolol in Angiosarcoma (NCT04518124) | The Netherlands Cancer Institute | 2019-12-27 |
| Novel Ga68-PSMA PET/CT-tracer to Differentiate Between Radiation Necrosis and Tumor Progression in Brain Metastases (NCT07511933) | The Netherlands Cancer Institute | 2019-12-24 |
| The SONImage Study (NCT04125277) | The Netherlands Cancer Institute | 2019-12-05 |
| INtra-operative Evaluation of a Novel FLUorescENt C-mEt Tracer in Penile and Tongue (NCT04574427) | The Netherlands Cancer Institute | 2019-11-13 |